“Biomodulatory Materials.”
Bret Ulery, Ph.D.
August 19th @12noon-1 pm CST
Dr. Bret Ulery is an Assistant Professor in the Department of Biomedical, Biological & Chemical Engineering at the University of Missouri. He received a Bachelor of Science in Engineering degree in chemical engineering and a Bachelor of Science degree in biochemistry from the University of Iowa in 2006. In 2010, he earned his Ph.D. in chemical engineering with a graduate minor in immunobiology in the lab of Dr. Balaji Narasimhan at Iowa State University. Following completion of his doctoral studies, Dr. Ulery spent two years as a Postdoctoral Fellow in Dr. Cato Laurencin’s research group in the Institute for Regenerative Engineering at the University of Connecticut Health Center followed by 2 years as a Postdoctoral Scholar under the advisement of Dr. Matt Tirrell at the University of Chicago before joining the MU faculty in 2014. Dr. Ulery has authored some 55 peer-reviewed publications, manuscript submissions, book chapters, and technology disclosures, in various journals including Advanced Healthcare Materials, Nature Scientific Reports, Pharmaceutical Research, PLoS One, and more. As Principal Investigator of the Biomodulatory Materials Engineering Laboratory (BioMEL), Dr. Ulery diverse team of 22 researchers (6 doctoral students, 3 master’s students, 11 undergraduate students, 1 medical resident & 1 research engineer) has broad collaborative reach and capabilities working with 45 faculty members across 15 department in 5 colleges at MU. BioMEL focuses on the design, development, and production of novel biomaterials for a variety of biomedical applications primarily in the fields of immunology and regenerative medicine to address a wide range of unmet clinical needs. BioMEL aims to advance the fields of regenerative engineering and immunoengineering by focusing on engineering the physicochemical properties of biomaterials to allow them to directly modulate cell and tissue responses. These novel biomaterials, defined as biomodulatory materials, are being utilized individually or in combination with bioactive factors to produce desirable biomedical outcomes.
It is our pleasure to have Dr. Bret Ulery join the Oral and Craniofacial Sciences Virtual Seminar Series on August 19th to present an overview of his investigations into biomodulatory materials that his team is creating to regenerate complex tissues as well as treat autoimmune diseases and cancer.
For a preview of upcoming seminars on our program see the 2020 Oral and Craniofacial Sciences Seminar Schedule.